Genitourinary (GU) cancers, including prostate, bladder, renal and testicular malignancies, represent a heterogeneous group of diseases with varying ...

There is a well-known saying among nuclear physicists that commercial nuclear fusion is about ten years away – and always will be. But a series of announcements by American startups and state-backed ...

An awe-inspiring science project by a Dallas ISD seventh-grader is now drawing national attention, as the student works to secure a Guinness World Record as the youngest person to achieve nuclear ...

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during ...

Eighty-five original research projects from aspiring physician-scientists were on display at the 2026 Medical Student Research Forum at the Jacobs School of Medicine and Biomedical Sciences.

For billions of years, the sun reigned supreme as the only fusion reactor in our solar system, leveraging its immense gravitational pressure and intense heat to overcome an atomic nuclei’s natural ...

Feb. 12, 2026 8:30 AM ETProfound Medical Corp. (PROF), PRN:CA “We are deeply grateful to INOVAIT for supporting a vision where AI‑enabled, image‑guided therapies like TULSA-PRO are not only developed ...